Quantification of lipoprotein subclasses by proton nuclear magnetic resonance-based partial least-squares regression models.
暂无分享,去创建一个
Søren Balling Engelsen | Lars Nørgaard | Henrik Toft Pedersen | Marianne Dyrby | S. Toubro | M. Dyrby | S. Engelsen | H. T. Pedersen | L. Nørgaard | J. Dyerberg | Martin Petersen | Søren Toubro | Martin Petersen | Jørn Dyerberg | Marianne Dyrby
[1] W C Willett,et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.
[2] D. Seligson,et al. Clinical Chemistry , 1965, Bulletin de la Societe de chimie biologique.
[3] I. Lemieux,et al. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects. , 1999, Diabetes & metabolism.
[4] W. Kannel,et al. Lipoproteins, cardiovascular disease, and death. The Framingham study. , 1981, Archives of internal medicine.
[5] Rasmus Bro,et al. Analysis of lipoproteins using 2D diffusion-edited NMR spectroscopy and multi-way chemometrics , 2005 .
[6] D W Bennett,et al. Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. , 1991, Clinical chemistry.
[7] R. Krauss,et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. , 1996, JAMA.
[8] Peter S. Belton,et al. Magnetic Resonance in Food Science , 1995 .
[9] J Keul,et al. Structure of human low-density lipoprotein subfractions, determined by X-ray small-angle scattering. , 1990, Biochimica et biophysica acta.
[10] C. J. Knill,et al. Magnetic resonance in food science , 1997 .
[11] B. Griffin,et al. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects. , 1999, Clinical science.
[12] Jimmy D Bell,et al. Quantification of biomedical NMR data using artificial neural network analysis: Lipoprotein lipid profiles from 1H NMR data of human plasma , 1995, NMR in biomedicine.
[13] M. Laakso,et al. Lipids and Lipoproteins Predicting Coronary Heart Disease Mortality and Morbidity in Patients With Non‐Insulin‐Dependent Diabetes , 1993, Circulation.
[14] J. Hokanson,et al. Characterization of low‐density lipoprotein subclasses: methodologie approaches and clinical relevance , 1994, Current opinion in lipidology.
[15] R. Krauss,et al. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. , 1992, Clinical chemistry.
[16] W. Castelli. Lipids, risk factors and ischaemic heart disease. , 1996, Atherosclerosis.
[17] R. Krauss,et al. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. , 1982, Journal of lipid research.
[18] R. Krauss,et al. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. , 1996, JAMA.
[19] G. Dagenais,et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. , 1997, Circulation.
[20] J. D. de Certaines,et al. Quantification of plasma lipoprotein fractions by wavelet transform time‐domain data processing of the proton nuclear magnetic resonance methylene spectral region , 1998, NMR in biomedicine.
[21] T. Bathen,et al. Quantification of plasma lipids and apolipoproteins by use of proton NMR spectroscopy, multivariate and neural network analysis , 2000, NMR in biomedicine.